HB 1574 - AS INTRODUCED
2018 SESSION
18-2272
01/06
HOUSE BILL 1574
SPONSORS: Rep. Janigian, Rock. 8; Rep. W. Marsh, Carr. 8; Rep. Gay, Rock. 8; Sen. Fuller Clark, Dist 21
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
ANALYSIS
This bill requires a health care provider and a patient to sign a form upon dispensing controlled drugs explaining the addictive nature of such drugs.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
18-2272
01/06
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Eighteen
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Statement of Intent. The general court hereby recognizes that the opioid crisis continues to grip our communities. Many persons become addicted after being prescribed opioid pain killers by their health care provider for an injury they have sustained. Patients are often given a choice to take an alternative pain killer or the opioid pain killer the health care provider has prescribed. This may give the patient a false sense of security that either is fine to take. Unfortunately, depending on the patient, he or she may become addicted to the opioid that was prescribed.
2 New Section; Controlled Drug Act; Opioid Disclosure. Amend RSA 318-B by inserting after section 318-B:1-c the following new section:
318-B:1-d Disclosure Form for Opioid Prescriptions. Licensed health care providers shall require patients to sign a disclosure form informing the patient that taking opioid drugs could possibly lead to addiction and that such drugs should only be taken if pain is severe. The form shall also be signed by the health care provider stating that the provider has explained the addictive nature of opioid drugs and that the patient may be able to use an alternative pain killer, if that is the case. If the patient may be able to use an alternative medication, the form shall include a statement to that effect and that it would be a preferable course of action. The commissioner may adopt rules, pursuant to RSA 541-A, relative to the form and content of the form required under this section.
3 Effective Date. This act shall take effect 60 days after its passage.
| Date | Body | Type |
|---|---|---|
| Jan. 23, 2018 | House | Hearing |
| Jan. 24, 2018 | House | Exec Session |
| House | Floor Vote | |
| Feb. 7, 2018 | House | Floor Vote |
Feb. 8, 2018: Inexpedient to Legislate: MA VV 02/08/2018 HJ 3 P. 6
: Committee Report: Inexpedient to Legislate (Vote 18-0; CC)
Feb. 7, 2018: Committee Report: Inexpedient to Legislate for 02/07/2018 (Vote 18-0; CC) HC 5 P. 9
Jan. 24, 2018: Executive Session: 01/24/2018 LOB 205
Jan. 23, 2018: Public Hearing: 01/23/2018 10:00 AM LOB 205
Jan. 3, 2018: Introduced 01/03/2018 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 15